2025-08-26 - Analysis Report
Okay, here's a report analyzing Transmedics Group Inc (TMDX) based on the provided data.

## TMDX (Transmedics Group Inc) Stock Analysis Report

**Company Overview:** Transmedics Group Inc. is a medical technology company pioneering a novel approach to organ preservation for transplantation.

### 1.  Performance vs. S&P 500 (VOO)

*   **TMDX Cumulative Return:** 217.30%
*   **VOO (S&P 500) Cumulative Return:** 38.06%
*   **Absolute Deviation (Current):** 192.9%
*   **Relative Deviation (Current):** 62.7% (This indicates the current deviation is at the 62.7th percentile of its historical range).

**Analysis of Alpha and Beta:**

| Year        | CAGR   | MDD   | Alpha   | Beta  | Cap(B) |
| ----------- | ------ | ----- | ------- | ----- | ------ |
| 2019-2021   | -4.0%  | 63.4% | -5.0%   | 0.8   | 0.7   |
| 2020-2022   | 140.0% | 68.3% | 150.0%  | 0.2   | 2.1   |
| 2021-2023   | 95.0%  | 69.4% | 86.0%   | 0.1   | 2.7   |
| 2022-2024   | 147.0% | 82.8% | 117.0%  | -0.0  | 2.1   |
| 2023-2025   | 98.0%  | 82.8% | 54.0%   | -0.0  | 3.9   |

*   **Analysis:**  TMDX has significantly outperformed the S&P 500 over the periods analyzed, demonstrated by a high level of alpha and large outperformance of the CAGR vs S&P500. However, it also exhibits high volatility (MDD), and low beta values (0.2 ~ -0.0) indicates the stock's price has been relatively immune to market factors during 2020-2025 period, with a tendency to exhibit independent movement.. The high alpha values indicate strong risk-adjusted returns.

### 2.  Recent Stock Price Movement

*   **Current Price:** $114.97
*   **Previous Close:** $119.85
*   **Change:** -$4.07 (Significant drop from previous close)
*   **5-Day Moving Average:** 119.64
*   **20-Day Moving Average:** 121.36
*   **60-Day Moving Average:** 123.98

*   **Analysis:** The stock price has experienced a notable decline recently. The current price is below all three moving averages (5, 20, and 60 days), suggesting a potential short-term downtrend. The significant negative change from the previous close ($119.85 to $114.97) indicates strong selling pressure.

### 3.  Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.32 (Low Risk)
*   **RSI:** 38.76 (Approaching oversold territory, potentially indicating a buying opportunity)
*   **PPO:** -0.63 (Negative, suggesting a downtrend but not significantly oversold)
*   **Hybrid Signal:** Cash 60% (Sell 60% of holdings) - Suggests a cautious approach, potentially due to recent price volatility and the low risk MRI.
*   **Recent (20-day) Relative Deviation Change:** -6.0 (Negative - indicating a recent decline in relative performance)
*   **Expected Return:** 78.6% (Long-term projected outperformance vs. S&P 500)

*   **Analysis:** The indicators present a mixed picture. The MRI suggests low market risk, while the RSI approaches oversold. The negative PPO and hybrid signal lean towards caution in the short term. However, the high expected return (78.6%) suggests strong long-term potential. The significant price change from the previous close has triggered the hybrid signal to recommend reducing holdings.

### 4.  Recent News & Significant Events

*   **[2025-08-22]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-26]:** Analyst discussions on recent performance and industry trends.
*   **[2025-08-23]:** Notable stock volatility due to recent news, earnings, or executive actions.
*   **[2025-08-24]:** Market experts highlight risks and opportunities.

*   **Analysis:** Recent news points to significant activity and volatility surrounding TMDX, likely impacting investor sentiment and stock price. These news events should be investigated further to understand their specific impacts.

### 5.  Recent Earnings Analysis

| 날짜       | EPS  | 예상 EPS |
| ---------- | ---- | -------- |
| 2025-07-30 | 0.92 | 0.48     |
| 2025-05-08 | 0.7  | 0.29     |
| 2025-02-27 | 0.19 | 0.22     |
| 2024-10-28 | 0.12 | 0.29     |
| 2024-07-31 | 0.35 | 0.21     |

*   **Analysis:** TMDX has consistently beat EPS estimates in recent quarters, indicating strong financial performance and potential positive investor sentiment, with significant positive beat in EPS for 2025-07-30 and 2025-05-08

### 6. Financial Information:

Revenue and Profitability:

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-06-30 | \$0.16B  | 61.38%        |
| 2025-03-31 | \$0.14B  | 61.47%        |
| 2024-12-31 | \$0.12B  | 59.21%        |
| 2024-09-30 | \$0.11B  | 55.94%        |
| 2024-06-30 | \$0.11B  | 60.59%        |

Capital and Profitability:

| Quarter    | Equity    | ROE     |
| ---------- | ---------- | -------- |
| 2025-06-30 | \$0.32B  | 10.97%  |
| 2025-03-31 | \$0.27B  | 9.64%   |
| 2024-12-31 | \$0.23B  | 3.00%   |
| 2024-09-30 | \$0.21B  | 2.01%   |
| 2024-06-30 | \$0.19B  | 6.42%   |

*   **Analysis:** The company shows consistent revenue growth and high-profit margins. Equity and ROE have also been increasing, suggesting improved financial health and profitability. The consistently increasing revenue, high profit margins and high ROE are a sign of successful investments.

### 7.  Overall Summary and Recommendation

TMDX has demonstrated significant outperformance compared to the S&P 500, driven by strong earnings, revenue growth, and high-profit margins. However, the stock has experienced recent volatility and a price decline.

*   **Positive Factors:** High alpha, strong revenue and earnings growth, high-profit margins, increasing ROE, and a high expected return.
*   **Negative Factors:** Recent price decline, recent volatility, negative PPO, and a hybrid signal suggesting a reduction in holdings.

**Recommendation:**

Given the mixed signals, a cautious approach is warranted.

*   **Short-term:** The recent price decline and negative technical indicators suggest potential for further downside. Investors may consider waiting for a stabilization in price and positive confirmation before adding to their positions.
*   **Long-term:** TMDX has strong fundamentals and a high expected return. Investors with a long-term horizon and a higher risk tolerance may consider accumulating shares during periods of weakness.

**Important Note:** This analysis is based solely on the provided data. A comprehensive investment decision should consider additional factors, including a thorough review of the recent news events, company filings, and industry trends.
